From Casetext: Smarter Legal Research

Mullen v. Astrazeneca Pharms., LP

UNITED STATES DISTRICT COURT CENTRAL DISTRICT OF ILLINOIS PEORIA DIVISION
May 22, 2017
Case No. 1:17-cv-01220-JES-JEH (C.D. Ill. May. 22, 2017)

Opinion

Case No. 1:17-cv-01220-JES-JEH

05-22-2017

GEORGE MULLEN, Plaintiff, v. ASTRAZENECA PHARMACEUTICALS, LP and ASTRAZENECA, LP, Defendants.


Order

The Plaintiff, George Mullen, filed a Complaint on May 19, 2017, including Defendants Astrazeneca Pharmaceuticals, LP and Astrazeneca, LP. (D. 1). The Plaintiff's Complaint asserts diversity of citizenship as a basis for this Court's subject matter jurisdiction. Id. at pg. 4. The allegations of the Complaint are not sufficient to support that assertion.

Citations to the Docket in this case are abbreviated as "D. ___." --------

The Court may sua sponte raise the issue of federal subject matter jurisdiction. Tylka v. Gerber Products Co., 211 F.3d 445, 447 (7th Cir. 2000) (citations omitted). Asserting jurisdiction on the basis of "information and belief" is insufficient to invoke diversity jurisdiction. America's Best Inns, Inc. v. Best Inns of Abilene, L.P., 980 F.2d 1072, 1074 (7th Cir. 1992) ("to the best of my knowledge and belief" is insufficient to invoke diversity jurisdiction); Page v. Wright, 116 F.2d 449, 451 (7th Cir. 1940) (expressing serious doubts as to whether the record could be sustained in the face of a direct jurisdictional attack where diversity jurisdiction was asserted, in part, based upon information and belief). Additionally, a complaint based on diversity jurisdiction must allege the state of incorporation and principal place of business for each of the named corporations, and those allegations must be based on the state of things at the time the action was brought. 28 USC § 1332(c)(1); Grupo Dataflux v Atlas Global Group, LP, 541 US 567, 570-71 (2004).

The Plaintiff asserts some of the basis for the Court's jurisdiction "[u]pon information and belief" and "[o]n information and belief[.]" (D. 1 at pp. 2-3; 33). The Plaintiff further fails to allege the Defendants' principal places of business. Id. at pg. 2. Therefore, the Plaintiff's Complaint is not sufficient to invoke diversity jurisdiction.

The Court may grant leave to amend defective allegations of subject matter jurisdiction pursuant to 28 U.S.C. § 1653. See also, Leaf v. Supreme Court of State of Wis., 979 F.2d 589, 595 (7th Cir. 1992) ("leave to amend defective allegations of subject matter jurisdiction should be freely given") (citations omitted). Accordingly, it is hereby ORDERED that the Plaintiff file an Amended Complaint not later than fourteen (14) days from the date of entry of this Order. In the Amended Complaint, the Plaintiff shall properly allege the basis for the Court's jurisdiction.

It is so ordered.

Entered on May 22, 2017.

s/ Jonathan E. Hawley

U.S. MAGISTRATE JUDGE


Summaries of

Mullen v. Astrazeneca Pharms., LP

UNITED STATES DISTRICT COURT CENTRAL DISTRICT OF ILLINOIS PEORIA DIVISION
May 22, 2017
Case No. 1:17-cv-01220-JES-JEH (C.D. Ill. May. 22, 2017)
Case details for

Mullen v. Astrazeneca Pharms., LP

Case Details

Full title:GEORGE MULLEN, Plaintiff, v. ASTRAZENECA PHARMACEUTICALS, LP and…

Court:UNITED STATES DISTRICT COURT CENTRAL DISTRICT OF ILLINOIS PEORIA DIVISION

Date published: May 22, 2017

Citations

Case No. 1:17-cv-01220-JES-JEH (C.D. Ill. May. 22, 2017)